- Home
- DDL vs PSNL Comparison
DDL vs PSNL Comparison
Compare DDL & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDL | PSNL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.3M | 729.1M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DDL | PSNL |
|---|---|---|
| Price | $2.62 | $6.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 1.0M | ★ 1.3M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $7.06 | $16.94 |
| Revenue Next Year | $10.31 | $36.58 |
| P/E Ratio | $16.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $2.83 |
| 52 Week High | $3.41 | $11.50 |
Technical Indicators
Market Signals| Indicator | DDL | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 34.61 |
| Support Level | $2.58 | $4.31 |
| Resistance Level | $3.07 | $6.94 |
| Average True Range (ATR) | 0.10 | 0.71 |
| MACD | -0.03 | -0.19 |
| Stochastic Oscillator | 5.79 | 5.95 |
Price Performance
Historical ComparisonAbout DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.